VectorBuilder to Present on Advancing AAV-Based Therapies at ARVO 2026

CHICAGO--(BUSINESS WIRE)-- #BioTechNews--VectorBuilder, a global leader in gene delivery technologies and CDMO solutions, will participate in the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, taking place in Denver, Colorado, from May 3 to 7. As AAV-based gene therapies continue to gain traction in ophthalmology, attention is shifting toward the underlying factors that influence consistency, durability, and clinical performance. Variability in vector design and production remains